2017
Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa
Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, Carmona S, Sherman G, Fox MP. Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2017, 74: 383-389. PMID: 28225717, PMCID: PMC5324708, DOI: 10.1097/qai.0000000000001284.Peer-Reviewed Original ResearchConceptsHIV careNational Health Laboratory Service databaseLow CD4 cell countsNational Antiretroviral Therapy ProgramCD4 cell countObservational cohort studyAntiretroviral therapy programsAntiretroviral therapyCohort studyPostpartum womenPublic clinicsService databaseCell countTherapy programCareWomenLTFUClinicOne-thirdDaysPatientsPregnancyTherapy
2009
Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL. Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol. BMC Pediatrics 2009, 9: 49. PMID: 19664210, PMCID: PMC2746190, DOI: 10.1186/1471-2431-9-49.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-HIV AgentsBlood Cell CountDouble-Blind MethodFemaleFollow-Up StudiesGestational AgeHematocritHemoglobinsHIVHIV InfectionsHumansIncidenceInfantInfant, NewbornMalawiNevirapinePregnancyPregnancy Complications, InfectiousRetrospective StudiesRNA, ViralTanzaniaTreatment OutcomeYoung AdultZambiaConceptsHIV infectionPregnant African womenRandomized clinical trialsTime of laborComplete laboratory dataWeeks of ageNevirapine prophylaxisChild transmissionHIV exposureWeeks' gestationHIV statusPregnant womenNewborn infantsClinical trialsPublic clinicsHIVInfantsBiochemical measurementsCaucasian populationWomenLaboratory dataNormative dataAfrican womenInfectionWeeks
2002
Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men
DiCLEMENTE RJ, FUNKHOUSER E, WINGOOD G, FAWAL H, HOLMBERG SD, VERMUND SH. Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men. Southern Medical Journal 2002, 95: 421-425. PMID: 11958240, DOI: 10.1097/00007611-200204000-00009.Peer-Reviewed Original ResearchConceptsProtease inhibitorsProtease inhibitor combination therapyActive heterosexual menHIV-infected personsHigh-risk sexual behaviorRisk reduction counselingInhibitor combination therapyAssociation of treatmentSexual behaviorUnprotected sexual behaviorHigh-risk practicesMedication useCombination therapyPotential confoundersPublic clinicsHealth statusCondom useCurrent sexual practicesMenTreatmentSexual practicesHeterosexual menInhibitorsAlabama communitiesCondomsProtease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men
DICLEMENTE R, FUNKHOUSER E, WINGOOD G, FAWAL H, HOLMBERG S, VERMUND S. Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay Men. Southern Medical Journal 2002, 95: 421-425. DOI: 10.1097/00007611-200295040-00010.Peer-Reviewed Original ResearchProtease inhibitorsProtease inhibitor combination therapyActive heterosexual menHIV-infected personsHigh-risk sexual behaviorRisk reduction counselingInhibitor combination therapyAssociation of treatmentSexual behaviorUnprotected sexual behaviorHigh-risk practicesMedication useCombination therapyPotential confoundersPublic clinicsHealth statusCondom useCurrent sexual practicesMenTreatmentSexual practicesHeterosexual menInhibitorsAlabama communitiesCondoms